TABLE 1

Patient demographics and baseline characteristics

CharacteristicValues for:
Prospective populationa (n = 5,053)Archived samplesb (n = 295)
Age (yr)
    Mean (SD)30.4 (9.8)27.5 (9.2)
    Median (range)28 (14–79)25 (18–70)
No. (%) of subjects by sex
    Female3,860 (76.4)295 (100)
    Male1,193 (23.6)0
No. (%) of subjects by race
    Black/African American2,843 (49.1)159 (53.9)
    White1,946 (38.5)116 (39.3)
    Asian91 (1.8)6 (2.0)
    American Indian/Alaska Native26 (0.5)0
    Native Hawaiian/Pacific Islander8 (0.2)1 (0.3)
    Multiple/other323 (6.4)13 (4.4)
    Not reported176 (3.5)0
No. (%) of subjects by ethnicity
    Not Hispanic/Latino3,541 (70.1)226 (76.6)
    Hispanic/Latino1,379 (27.3)58 (19.7)
    Unknown52 (1.0)2 (0.7)
    Not reported81 (1.6)9 (3.1)
No. (%) of subjects by self-reported symptom status
    Asymptomatic3,305 (65.4)145 (49.2)
    Symptomatic1,747 (34.6)150 (50.8)
No. (%) of subjects by pregnancy status (women only)
    Not pregnant3,811 (98.7)281 (95.3)
    Pregnant43 (1.1)9 (3.1)
    Unknown6 (0.2)5 (1.7)
No. (%) of subjects by clinic type
    Family planning3,130 (61.9)134 (45.4)
    STIc973 (19.3)120 (40.7)
    Obstetrics/gynecology797 (15.8)41 (13.9)
    Family planning/STI153 (3.0)0
  • a Participants enrolled in the prospective study population with designated infection status (infected or not infected) and final valid Cobas CT/NG test results.

  • b Archived samples from study COB-CTNG-282 from female participants with a designated N. gonorrhoeae PIS (infected or not infected), final valid Cobas CT/NG test results, and an adequate sample volume for testing.

  • c STI, sexually transmitted infection.